|
National Stock Number(NSN): 6505-01-153-4419 (6505011534419, 011534419)
| NIIN: |
01-153-4419 |
Item Name: |
FURAZOLIDONE ORAL S |
INC: |
77777 |
| FSC: |
6505
|
Assignment Date: |
May-15-1983 |
CRIT: |
N |
IIG: |
77777 |
| ISC: |
C |
Date Standardized: |
May-07-1983 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
May-01-2001 |
PMIC: |
A |
FIIG: |
A23900 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
4 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
1 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
FUROXONE |
04547
|
PROCTER & GAMBLE PHARMACEUTICALS, INC. |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
FUROXONE |
0MZB5
|
ROBERTS PHARMACEUTICAL CORP |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00149-0773-15 |
04547
|
PROCTER & GAMBLE PHARMACEUTICALS, INC. |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC54092-0430-60 |
0MZB5
|
ROBERTS PHARMACEUTICAL CORP |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
Z |
Q |
U |
1 |
A |
$14.64 |
BT |
|
C2201X- |
Apr-01-1996 |
H |
| DF |
JDC |
L |
|
Q |
U |
1 |
F |
$14.64 |
BT |
|
------- |
Apr-01-1996 |
H |
| DN |
JDC |
L |
|
Q |
U |
1 |
N |
$14.64 |
BT |
|
9L----- |
Apr-01-1996 |
H |
| DS |
JDC |
L |
|
Q |
U |
1 |
D |
$14.64 |
BT |
|
------- |
Apr-01-1996 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DN |
R |
REFER TO NON-STD NON-DMSB REV |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| SUCB |
UNIT OF ISSUE CUBE |
0.001 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.01 POUNDS |
| TEXT |
GENERAL CHARACTERISTICS ITEM DESCRIPTION |
FURAZOLIDONE ORAL SOL 50 MG PER 15 ML 60 ML |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Aug-04-2000 |
3 |
H |
|
|
|
|
| FSKX |
|
Aug-04-2000 |
3 |
H |
|
|
|
|
| N9LM |
|
Aug-04-2000 |
3 |
H |
|
|
|
|
|